利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

6 条记录 (耗时 0.013 秒)

    Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    1.
    发明授权
    Substance for lowering high cholesterol level in serum and methods for preparing and using the same 失效
    用于降低血清中高胆固醇水平的物质及其制备和使用方法

    公开(公告)号：US06174560B1

    公开(公告)日：2001-01-16

    申请号：US09190598

    申请日：1998-11-12

    申请人： Tatu Miettenen ,  Ingmar Wester ,  Hannu Vanhanen

    发明人： Tatu Miettenen ,  Ingmar Wester ,  Hannu Vanhanen

    IPC分类号： A23L0000

    CPC分类号： C07J9/00 ,  A23D7/0056 ,  A23D9/007 ,  Y10S426/804

    摘要： The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &bgr;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &bgr;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.

    摘要翻译： 本发明涉及降低血清中低密度脂蛋白胆固醇水平并且是脂溶性β-谷甾醇脂肪酸酯的物质及其制备和使用方法。 该物质可以口服作为食品添加剂，食品替代品或补充剂。 日耗量在约0.2至约20g /天之间的β-谷甾烷醇酯已被证明可减少胆汁和内源性胆固醇的吸收。

    Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    3.
    发明授权
    Substance for lowering high cholesterol level in serum and methods for preparing and using the same 失效
    用于降低血清中高胆固醇水平的物质及其制备和使用方法

    公开(公告)号：US07691834B2

    公开(公告)日：2010-04-06

    申请号：US11201313

    申请日：2005-08-11

    申请人： Tatu Miettenen ,  Hannu Vanhanen ,  Ingmar Wester

    发明人： Tatu Miettenen ,  Hannu Vanhanen ,  Ingmar Wester

    IPC分类号： A01N45/00

    CPC分类号： C07J9/00 ,  A23D7/0056 ,  A23D9/007 ,  Y10S426/804

    摘要： The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble β-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the β-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.

    摘要翻译： 本发明涉及一种降低血清中LDL胆固醇水平的物质，它是脂溶性β-谷甾醇脂肪酸酯，以及其制备和使用方法。 该物质可以口服作为食品添加剂，食品替代品或补充剂。 日用量约0.2至约20g /天的β-谷甾醇酯已被证明可减少胆汁和内源性胆固醇的吸收。

    Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    4.
    发明授权
    Substance for lowering high cholesterol level in serum and methods for preparing and using the same 失效
    用于降低血清中高胆固醇水平的物质及其制备和使用方法

    公开(公告)号：US06544973B1

    公开(公告)日：2003-04-08

    申请号：US09713030

    申请日：2000-11-16

    申请人： Tatu Miettenen ,  Ingmar Wester ,  Hannu Vanhanen

    发明人： Tatu Miettenen ,  Ingmar Wester ,  Hannu Vanhanen

    IPC分类号： A61K3156

    CPC分类号： C07J9/00

    摘要： The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &bgr;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &bgr;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.

    摘要翻译： 本发明涉及降低血清中低密度脂蛋白胆固醇水平并且是脂溶性β-谷甾醇脂肪酸酯的物质及其制备和使用方法。 该物质可以口服作为食品添加剂，食品替代品或补充剂。 日耗量在约0.2至约20g /天之间的β-谷甾烷醇酯已被证明可减少胆汁和内源性胆固醇的吸收。